Here’s a nicely written ad for Quintiles as seen in the latest PharmaVoice edition. It has a nice rhythm to it from the onset. Nicely done.

Original image available on AdPharm.net – (2949 x 1800 pixels)

The new health is the rapidly morphing world of biopharma.

In a world of genome mapping and supercomputers, The New Health has enormous potential.

In a world of rising costs and changing regulations, The New Health faces confounding obstacles.

The destination is a worthy one: turning healthy ideas into healthy people. But the journey is harder now. It calls for new efficiencies, faster outcomes, new sources of capital, smarter ways of assessing risk, global ways of executing.

The New Health needs a new kind of ally.

Call us. With 27 years of experience and capabilities in clinical, commercial, consulting and capital, we’re uniquely positioned to help you navigate risk and seize opportunity in the New Health. See how at www.quitines.com/newhealth

Brand name: Quintiles
Generic name/category: Corporate communications
Company: Quintiles
Country/Market: USA, North America
Indication(s)/use: consultation in clinical, commercial and capital
Target: Trade
Tagline: Navigating the new health
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: PharmaVoice – February 2010

To see all of this brand’s ads on AdPharm, click here

Ron Davis, Pharm.D.
Customers have questions?
You’re used to answering just about any question customers come up with.

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

If efficacy is too painful to take, where’s the efficacy?

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

To be with my mates, to be part of the crowd, to be myself

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Prevention – December 2009

To see all of this brand's ads on AdPharm, click here

Ezetimibe/simvastatin is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Ezetimibe reduces blood cholesterol by inhibiting absorption of cholesterol by the small intestine by acting at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Now approved
For acute and maintenance treatment of schizophrenia
Rethink the way you treat

New Once-Monthly Invega Sustenna

Brand name: Invega Sustenna
Generic name/category: paliperidone palmitate, atypical antipsychotic
Company: Janssen
Country/Market: USA, North America
Indication(s)/use: acute and maintenance treatment of schizophrenia in adults
Target: Healthcare Professionals (HCP)
Tagline: Rethink the way you treat
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric Services – November 2009

To see all of this brand's ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.